Influenza Market Analysis and Reports | UK Conference Series

Market Analysis - Influenza 2017

Scope and Importance of Influenza and Zoonotic Diseases

Influenza, is caused by infection with RNA viruses of the family Orthomyxiviridae called influenza virus. These infections can contaminate both birds and mammals. The disease spreads through droplets (aerosols) that start from coughing and sneezing. By and large individuals have disarray with influenza with a bad cold. Flu and cold symptoms may include a runny/blocked nose, sore throat, and cough. Some of the complications caused by influenza may include bacterial pneumonia, dehydration, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes. Kids may get sinus problems and ear infections. The infection is transmitted effortlessly from individual to individual by means of droplets and small particles produced when infected people cough or sneeze. Influenza tends to spread rapidly in seasonal epidemics. Most infected people recover within one to two weeks without requiring medical treatment. However, in the very young, the elderly, and those with other serious medical conditions, infection can lead to severe complications of the underlying condition, pneumonia and death. Zoological surveillance is led all over to explore the etiological components of illness and foundations for spreading contaminations from animals and its preventive measures. The evaluation and checking of the health of communities and populations at risk to identify health problems and priorities. Advance the correspondence of epidemiological techniques and discoveries among disease transmission experts all through the world and among all others worried with wellbeing. Co-work with both national and global associations which are worried with the advancement of wellbeing in the use of epidemiological techniques in the arrangement of issues. Enhance the scattering of epidemiological discoveries broadly and globally. To improve the biostatisticians' use of measurable techniques to the arrangement of issues experienced in general wellbeing and pharmaceutical.

Why Birmingham?

Zoonotic diseases are constantly threaten the public health. Recent examples are the outbreaks of avian influenza and SARS. The development of a zoonosis will frequently be the consequence of complex mix of risk factors, in which the intensity of contact between the original reservoir (the transitional reservoir and vectors) and people is critical. Prevention and control of the emergence of zoonoses is in this manner extremely troublesome and may require a double-edged procedure. From one perspective, readiness should be enhanced however much as could reasonably be expected in the event that it concerns zoonoses that are considered as a potential hazard for general wellbeing in  Europe (get ready for the known or potentially possible). Then again, open and  veterinary wellbeing frameworks, and the communication of the two in Europe, should be reinforced to produce essential logical information on missing connections, to incorporate current information and to grow new courses for early cautioning and episode control to get ready however much as could reasonably be expected for new and right now obscure zoonoses. Purposeful activity at European level will be required to react opportune and successfully to zoonoses undermining general wellbeing in Europe. Similarly every year, approximately 15 000 people die of the severe consequences of influenza. Older people and individuals with specific health conditions run a particularly high risk of suffering complications from an infection with the influenza virus MEA researchers analyse the causes. Public Health England’s (PHE’s) Influenza surveillance section at PHEColindale co-ordinates and collates flu surveillance for the UK.  

Societies associated with Influenza and Zoonotic Diseases research around the Globe

  • European Scientific Working group on Influenza (ESWI)
  • International Society for Influenza and other Respiratory Virus Diseases
  • Infectious Diseases Society of America
  • European Society of Clinical Microbiology and Infectious Diseases
  • International Society for Infectious Diseases
  • Australasian Society for Infectious Diseases
  • Clinical Infectious Diseases Society
  • Society for Zoonotic Ecology and Epidemiology 
  • Ecological Society of America
  • Edinburgh Infectious Diseases
  • European Scientific Counsel Companion Animal Parasites

Market research on Influenza

The influenza market is in terms of revenue (USD million), for the period from 2015 to 2020. Global Influenza Market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. In terms of market value, North America is estimated the largest market with US$2.1 billion in 2016 while Europe is projected to be the fastest growing market for Influenza vaccines during the analysis period 2016-2022 with a CAGR of 11.7%. Worldwide market for Influenza Vaccines is analyzed in both volumes in doses and value in USD for the period from 2012 through to 2022. The global market for overall influenza is estimated to be US$6.1 billion in 2016 and anticipated to reach US$10.2 billion by 2022, witnessing a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining. However, therapeutics segment is projected to be the fastest growing with a CAGR of 11% during the aforementioned analysis period.

Market research on Zoonotic Diseases

·         Future growth of global animal health market is expected to be led by inclining prevalence of zoonotic diseases leading to increased demand for animal health products. Rising level of awareness among the consumers related to zoonotic and other communicable diseases caused by animals such as Q fever, Tularemia, Rabies and others has resulted in increased demand for animal health products. It has been predicted by World Health Organization (WHO) that around 55,000 people present in Asia and Africa, as of August, 2016 are suffering from rabies and the expense of their treatment in cumulative would amount at USD 590 million annually on these two continents. It has also been observed that 13 major zoonotic diseases which majorly include tuberculosis and bird flu are responsible for 2.2 million deaths globally every year. Presently, the global population is highly dependent on animal protein such as milk, meat, eggs and others for their daily needs, which is expected to lead to an increase in the percentage of zoonotic diseases during the future. The global veterinary vaccines market is poised to reach USD 7.68 Billion by 2021 from USD 5.81 Billion in 2016, at a CAGR of 5.8% from 2016 to 2021. The veterinary vaccines market is segmented on the basis of product, disease, technology, and region. The veterinary vaccine products market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to increasing awareness about vaccination, increasing number of zoonotic diseases in the human population, and the increasing number of pets and pet owners.

Worldwide Industries Associated with Influenza and Zoonotic Diseases Research:

  • Gamma Vaccines
  • bioCSL (CSL)
  • Bavarian Nordic
  • Chiron Corporation
  • Vaxart
  • Novartis
  • Inovio Pharmaceuticals
  • Novarx
  • Flugen
  • Sanofi Pasteur
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Immunomic Therapeutics
  • GlaxoSmithKline
  • Bharat Biotech
  • Indian Immunologicals
  • Pfizer
  • MedImmune (AstraZeneca)
  • NovaDigm Therapeutics
  • Crucell (Janssen Pharmaceutical)
  • Merck
  • Lonza
  • Pharmajet

Some Zoonotic Disease Worlwide

                                             Fig 1: Common Zoonotic Diseases 

Infections with Zoonotic Diseases

                                          Fig 2: Zoonotic Diseases Infection 

Worldwide deaths due to Zoonotic Diseases

                                   Fig 3 : Deaths due to Zoonotic Diseases